Skip to main content
OpenTrials
Completed

NCT Number: NCT03265925

Brain Network Activation Analysis in Epilepsy

This is a prospective study investigating the utility of Brain Network Activation (BNA) analysis in patients with epilepsy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

RUSH University medical center

Chicago, Illinois, 60612, United States

About this study

BNA technology is based on a network model to depict functional connectivity. The descriptive network model approach provides insights regarding inter-connectivity of brain networks and can describe the temporal-spatial brain activation patterns applied to various types of data-sets including EEG, MEG and fMRI.

In this study it is proposed that synchronization in brain activity may be disrupted in patients who experience frequent seizures and may correspond to functional impairments (e.g., memory, processing speed). As such, BNA analysis may provide additional data that complement current functional assessments, inform clinical assessment and management of epilepsy, and identify subgroups of patients that might be at risk for poor treatment outcomes.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants will be between ages 18-50 years old
  • Able to speak, read and understand English sufficiently to understand the nature of the study, and to allow completion of all study assessments
  • Willingness to participate and able to give informed consent
  • If corrected vision: only Glasses should be used during the study testing

Exclusion criteria

  • History of significant head trauma
  • Evidence of other neurologic disease
  • Any diagnosed psychiatric or systemic condition that could lead to a change in brain activity or volume (e.g., stroke, Alzheimer's disease, alcoholism).
  • Currently with lice or open wounds on scalp
  • Significant sensory deficits
  • Use of a hearing aid that occupies the ear canal
  • Substance abuse in the last 3 months and any clinically significant substance dependency
  • Additional exclusion criteria for controls are a history of any neurological disease or psychological illness.

Treatment and study plan

Primary outcomes

  1. Assess the BNA database for Epilepsy population and healthy controls.

    Time frame: Epilepsy subjects will perform the BNA testing at baseline prior to change in medication if applicable and 3-10 days following change in medication when applicable.

    Functional networks of brain activity in Epilepsy (Right and Left lobe) and healthy control individuals measured using analysis of EEG Event Related Potential (ERP) data. Clinical assessments battery will be utilized in order to examine different sets of BNA database for Epilepsy pathology and healthy controls.

Sponsors and collaborators

Lead sponsor

ElMindA Ltd

Industry

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Aug 29, 2017
Registry last updated
Sep 27, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.